Skip to main content
PMC home page
British Medical Journal logoLink to British Medical Journal
. 1969 Dec 27;4(5686):776–778. doi: 10.1136/bmj.4.5686.776

Intravenous glucose tolerance, insulin, glucose, and free fatty acid levels after myocardial infarction

S P Allison, M J Chamberlain, Pamela Hinton
PMCID: PMC1630323  PMID: 5359942

Abstract

Glucose tolerance tests performed on 12 patients within 15 hours of myocardial infarction and repeated two to four weeks later showed failure of insulin secretion, hyperglycaemia, glucose intolerance, and high free fatty acid levels. More pronounced changes were found in patients with cardiogenic shock. These findings suggest that the therapeutic use of potassium, glucose, and insulin should be re-evaluated.

Full text

PDF
776

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allison S. P., Hinton P., Chamberlain M. J. Intravenous glucose-tolerance, insulin, and free-fatty-acid levels in burned patients. Lancet. 1968 Nov 23;2(7578):1113–1116. doi: 10.1016/s0140-6736(68)91581-x. [DOI] [PubMed] [Google Scholar]
  2. Allison S. P., Prowse K., Chamberlain M. J. Failure of insulin response to glucose load during operation and after myocardial infarction. Lancet. 1967 Mar 4;1(7488):478–481. doi: 10.1016/s0140-6736(67)91097-5. [DOI] [PubMed] [Google Scholar]
  3. Allison S. P., Tomlin P. J., Chamberlain M. J. Some effects of anaesthesia and surgery on carbohydrate and fat metabolism. Br J Anaesth. 1969 Jul;41(7):588–593. doi: 10.1093/bja/41.7.588. [DOI] [PubMed] [Google Scholar]
  4. Coore H. G., Randle P. J. Regulation of insulin secretion studied with pieces of rabbit pancreas incubated in vitro. Biochem J. 1964 Oct;93(1):66–78. doi: 10.1042/bj0930066. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. DOLE V. P., MEINERTZ H. Microdetermination of long-chain fatty acids in plasma and tissues. J Biol Chem. 1960 Sep;235:2595–2599. [PubMed] [Google Scholar]
  6. Duncombe W. G. The colorimetric micro-determination of long-chain fatty acids. Biochem J. 1963 Jul;88(1):7–10. doi: 10.1042/bj0880007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Dykes J. R., Saxton C., Taylor S. H. Insulin secretion in cardiogenic shock. Br Med J. 1969 May 24;2(5655):490–490. doi: 10.1136/bmj.2.5655.490. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. ELLENBERG M., OSSERMAN K. E., POLLACK H. Hyperglycemia in coronary thrombosis. Diabetes. 1952 Jan-Feb;1(1):16–21. doi: 10.2337/diab.1.1.16. [DOI] [PubMed] [Google Scholar]
  9. HALES C. N., RANDLE P. J. Immunoassay of insulin with insulin-antibody precipitate. Biochem J. 1963 Jul;88:137–146. doi: 10.1042/bj0880137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. KOSAKA K., IDE T., KUZUYA T., MIKI E., KUZUYA N., OKINAKA S. INSULIN-LIKE ACTIVITY IN PANCREATIC VEIN BLOOD AFTER GLUCOSE LOADING AND EPINEPHRINE HYPERGLYCEMIA. Endocrinology. 1964 Jul;75:9–14. doi: 10.1210/endo-75-1-9. [DOI] [PubMed] [Google Scholar]
  11. Kurien V. A., Yates P. A., Oliver M. F. Free fatty acids, heparin, and arrhythmias during experimental myocardial infarction. Lancet. 1969 Jul 26;2(7613):185–187. doi: 10.1016/s0140-6736(69)91424-x. [DOI] [PubMed] [Google Scholar]
  12. Miller R. E., Soeldner J. S. Suppression of portal venous insulin concentration by epinephrine i the conscious monkey. Diabetologia. 1969 Jun;5(3):179–182. doi: 10.1007/BF01213676. [DOI] [PubMed] [Google Scholar]
  13. Oliver M. F., Kurien V. A., Greenwood T. W. Relation between serum-free-fatty acids and arrhythmias and death after acute myocardial infarction. Lancet. 1968 Apr 6;1(7545):710–714. doi: 10.1016/s0140-6736(68)92163-6. [DOI] [PubMed] [Google Scholar]
  14. Owen P., Thomas M., Opie L. Relative changes in free-fatty-acid and glucose utilisation by ischaemic myocardium after coronary-artery occlusion. Lancet. 1969 Jun 14;1(7607):1187–1190. doi: 10.1016/s0140-6736(69)92168-0. [DOI] [PubMed] [Google Scholar]
  15. Pentecost B. L., Mayne N. M., Lamb P. Controlled trial of intravenous glucose, potassium, and insulin in acute myocardial infarction. Lancet. 1968 May 4;1(7549):946–948. doi: 10.1016/s0140-6736(68)90903-3. [DOI] [PubMed] [Google Scholar]
  16. Porte D., Jr, Graber A. L., Kuzuya T., Williams R. H. The effect of epinephrine on immunoreactive insulin levels in man. J Clin Invest. 1966 Feb;45(2):228–236. doi: 10.1172/JCI105335. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. RANDLE P. J., GARLAND P. B., HALES C. N., NEWSHOLME E. A. The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet. 1963 Apr 13;1(7285):785–789. doi: 10.1016/s0140-6736(63)91500-9. [DOI] [PubMed] [Google Scholar]
  18. Ross H., Johnston I. D., Welborn T. A., Wright A. D. Effect of abdominal operation on glucose tolerance and serum levels of insulin, growth hormone, and hydrocortisone. Lancet. 1966 Sep 10;2(7463):563–566. doi: 10.1016/s0140-6736(66)93036-4. [DOI] [PubMed] [Google Scholar]
  19. SAMOLS E., MARKS V. INTERPRETATION OF THE INTRAVENOUS GLUCOSE TEST. Lancet. 1965 Feb 27;1(7383):462–463. doi: 10.1016/s0140-6736(65)91592-8. [DOI] [PubMed] [Google Scholar]
  20. Sodi-Pallares D., Ponce de León J., Bisteni A., Medrano G. A. Potassium, glucose, and insulin in myocardial infarction. Lancet. 1969 Jun 28;1(7609):1315–1316. doi: 10.1016/s0140-6736(69)92251-x. [DOI] [PubMed] [Google Scholar]
  21. VALLANCE-OWEN J., ASHTON W. L. Cardiac infarction and insulin antagonism. Lancet. 1963 Jun 8;1(7293):1226–1228. doi: 10.1016/s0140-6736(63)91860-9. [DOI] [PubMed] [Google Scholar]
  22. Valori C., Thomas M., Shillingford J. P. Urinary excretion of free noradrenaline and adrenaline following acute myocardial infarction. Lancet. 1967 Jan 21;1(7482):127–130. doi: 10.1016/s0140-6736(67)91033-1. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES